{
  "fullName": "Stephen B. Baylin",
  "slug": "stephen-b-baylin",
  "title": "MD, PhD",
  "specialty": "Cancer Epigenetics",
  "geography": {
    "city": "Unknown",
    "country": "USA"
  },
  "portraitUrl": "data:image/svg+xml;utf8,<svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 100 100\"><rect width=\"100\" height=\"100\" fill=\"%23300066\"/><text x=\"50\" y=\"50\" font-family=\"serif\" font-size=\"40\" fill=\"%23FFD700\" text-anchor=\"middle\" dy=\".3em\">SB</text></svg>",
  "tier": "TITAN",
  "rankingScore": 52,
  "hIndex": 206,
  "citations": [],
  "yearsActive": 30,
  "verifiedSurgeries": 0,
  "livesSaved": 28123,
  "techniquesInvented": [],
  "isPioneer": true,
  "isLeader": true,
  "affiliations": [
    {
      "hospitalName": "Johns Hopkins University"
    }
  ],
  "bio": "Stephen B. Baylin is a pioneer in Cancer Epigenetics at Johns Hopkins University, USA. With a D-Index of 206 and over 281,231 citations, they are among the world's most influential researchers.",
  "awards": [
    {
      "name": "High Impact Researcher",
      "year": 2024
    }
  ],
  "education": [],
  "socialMedia": {},
  "status": "LIVING"
}